What is the preferred DMARD in active spondyloarthropathy with psoriasis and sacroiliitis features in the setting of treated hepatitis C with negative viral load?

Given that the patient is treated and has a negative viral load, options for treating PsA are rather broad. Of course, if high-risk behaviors that increase the risk of developing hepatitis C persist, the options are very limited. In the anti-TNF class, I prefer etanercept due to its short half-life....